166 related articles for article (PubMed ID: 34917299)
1. Analgesic Effect of Bumetanide on Neuropathic Pain in Patients With Spinal Cord Injury.
Nasirinezhad F; Zarepour L; Hadjighassem M; Gharaylou Z; Majedi H; Ramezani F
Basic Clin Neurosci; 2021; 12(3):409-420. PubMed ID: 34917299
[TBL] [Abstract][Full Text] [Related]
2. Preliminary study of analgesic effect of bumetanide on neuropathic pain in patients with spinal cord injury.
Zarepour L; Gharaylou Z; Hadjighassem M; Shafaghi L; Majedi H; Behzad E; Hosseindoost S; Ramezani F; Nasirinezhad F
J Clin Neurosci; 2020 Nov; 81():477-484. PubMed ID: 33222966
[TBL] [Abstract][Full Text] [Related]
3. Role of NKCC1 and KCC2 in the development of chronic neuropathic pain following spinal cord injury.
Hasbargen T; Ahmed MM; Miranpuri G; Li L; Kahle KT; Resnick D; Sun D
Ann N Y Acad Sci; 2010 Jun; 1198():168-72. PubMed ID: 20536931
[TBL] [Abstract][Full Text] [Related]
4. Prevention of NKCC1 phosphorylation avoids downregulation of KCC2 in central sensory pathways and reduces neuropathic pain after peripheral nerve injury.
Mòdol L; Cobianchi S; Navarro X
Pain; 2014 Aug; 155(8):1577-1590. PubMed ID: 24813295
[TBL] [Abstract][Full Text] [Related]
5. The role of cation-dependent chloride transporters in neuropathic pain following spinal cord injury.
Cramer SW; Baggott C; Cain J; Tilghman J; Allcock B; Miranpuri G; Rajpal S; Sun D; Resnick D
Mol Pain; 2008 Sep; 4():36. PubMed ID: 18799000
[TBL] [Abstract][Full Text] [Related]
6. Expression and effect of sodium-potassium-chloride cotransporter on dorsal root ganglion neurons in a rat model of chronic constriction injury.
Tan CY; Wang YP; Han YY; Lu BH; Ji W; Zhu LC; Wang Y; Shi WY; Shan LY; Zhang L; Ma KT; Li L; Si JQ
Neural Regen Res; 2020 May; 15(5):912-921. PubMed ID: 31719257
[TBL] [Abstract][Full Text] [Related]
7. The chloride co-transporters, NKCC1 and KCC2, in experimental autoimmune encephalomyelitis (EAE).
Yousuf MS; Zubkow K; Tenorio G; Kerr B
Neuroscience; 2017 Mar; 344():178-186. PubMed ID: 28057537
[TBL] [Abstract][Full Text] [Related]
8. A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an NKCC1 Inhibitor, in Patients with Drug-Resistant Epilepsy.
Gharaylou Z; Tafakhori A; Agah E; Aghamollaii V; Kebriaeezadeh A; Hadjighassem M
CNS Drugs; 2019 Mar; 33(3):283-291. PubMed ID: 30784026
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of spinal cord injury induced edema and neuropathic pain: expression of multiple isoforms of wnk1.
Ahmed MM; Lee H; Clark Z; Miranpuri GS; Nacht C; Patel K; Liu L; Joslin J; Kintner D; Resnick DK
Ann Neurosci; 2014 Jul; 21(3):97-103. PubMed ID: 25206073
[TBL] [Abstract][Full Text] [Related]
10. Increased spinal cord Na⁺-K⁺-2Cl⁻ cotransporter-1 (NKCC1) activity contributes to impairment of synaptic inhibition in paclitaxel-induced neuropathic pain.
Chen SR; Zhu L; Chen H; Wen L; Laumet G; Pan HL
J Biol Chem; 2014 Nov; 289(45):31111-20. PubMed ID: 25253692
[TBL] [Abstract][Full Text] [Related]
11. Pre- and post-synaptic switches of GABA actions associated with Cl- homeostatic changes are induced in the spinal nucleus of the trigeminal nerve in a rat model of trigeminal neuropathic pain.
Wei B; Kumada T; Furukawa T; Inoue K; Watanabe M; Sato K; Fukuda A
Neuroscience; 2013 Jan; 228():334-48. PubMed ID: 23103796
[TBL] [Abstract][Full Text] [Related]
12. Na(+)/K(+)/Cl(-) cotransporter activates mitogen-activated protein kinase in fibroblasts and lymphocytes.
Panet R; Eliash M; Pick M; Atlan H
J Cell Physiol; 2002 Feb; 190(2):227-37. PubMed ID: 11807827
[TBL] [Abstract][Full Text] [Related]
13. The bumetanide-sensitive Na-K-2Cl cotransporter NKCC1 as a potential target of a novel mechanism-based treatment strategy for neonatal seizures.
Kahle KT; Staley KJ
Neurosurg Focus; 2008 Sep; 25(3):E22. PubMed ID: 18759624
[TBL] [Abstract][Full Text] [Related]
14. Bumetanide protects focal cerebral ischemia-reperfusion injury in rat.
Wang G; Huang H; He Y; Ruan L; Huang J
Int J Clin Exp Pathol; 2014; 7(4):1487-94. PubMed ID: 24817944
[TBL] [Abstract][Full Text] [Related]
15. The role of KCC2 and NKCC1 in spinal cord injury: From physiology to pathology.
Talifu Z; Pan Y; Gong H; Xu X; Zhang C; Yang D; Gao F; Yu Y; Du L; Li J
Front Physiol; 2022; 13():1045520. PubMed ID: 36589461
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the Na(+)/K(+)/Cl(-) cotransporter gene induces cell proliferation and phenotypic transformation in mouse fibroblasts.
Panet R; Marcus M; Atlan H
J Cell Physiol; 2000 Jan; 182(1):109-18. PubMed ID: 10567922
[TBL] [Abstract][Full Text] [Related]
17. Activation of 5-HT
Sánchez-Brualla I; Boulenguez P; Brocard C; Liabeuf S; Viallat-Lieutaud A; Navarro X; Udina E; Brocard F
Neuroscience; 2018 Sep; 387():48-57. PubMed ID: 28844001
[TBL] [Abstract][Full Text] [Related]
18. Role of NKCC1 and KCC2 in Epilepsy: From Expression to Function.
Liu R; Wang J; Liang S; Zhang G; Yang X
Front Neurol; 2019; 10():1407. PubMed ID: 32010056
[TBL] [Abstract][Full Text] [Related]
19. The Role of K
Kitayama T
Neurochem Res; 2018 Jan; 43(1):110-115. PubMed ID: 28677029
[TBL] [Abstract][Full Text] [Related]
20. Long-term administration of bumetanide improve functional recovery after spinal cord injury in rats.
Hashemizadeh S; Gharaylou Z; Hosseindoost S; Sardari M; Omidi A; Hosseini Ravandi H; Hadjighassem M
Front Pharmacol; 2022; 13():932487. PubMed ID: 36339604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
